JFGIW
ENTA icon

Johnson Financial Group Inc (Wisconsin)’s Enanta Pharmaceuticals ENTA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38K Hold
188
– – ﹤0.01% 768
2025
Q4 		$2.96K Hold
188
– – ﹤0.01% 765
2025
Q3 		$2.25K Buy
+188
New +$1.5K ﹤0.01% 922

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s ENTA Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 188 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #768.

Johnson Financial Group Inc (Wisconsin) first reported a position in ENTA in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.96K in Q4 2025. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 188 shares of Enanta Pharmaceuticals worth $2.38K as of Q1 2026.
  • Johnson Financial Group Inc (Wisconsin) left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #768 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Enanta Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Enanta Pharmaceuticals position peaked at $2.96K in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.